Viyash Scientific Limited (NSE:VIYASH)
India · Delayed Price · Currency is INR 250.35
-3.40 (-1.34%)
Sep 24, 2026, 11:10 AM IST
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 110.71 billion as of September 23, 2026. Its market cap has increased by 116.96% in one year.
Market Cap
110.71B
Enterprise Value
115.05B
Revenue
35.75B
Ranking
n/a
PE Ratio
52.38
Stock Price
250.35
ChartMarket Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 110.71B, an increase of 31,735.76%. That is a compound annual growth rate of 30.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 110.71B | 22.07% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 179.49B |
| Cohance Lifesciences | 176.15B |
| Alivus Life Sciences | 171.88B |
| Alembic Pharmaceuticals | 166.83B |
| NATCO Pharma | 146.21B |
| Sudeep Pharma | 129.21B |
| Akums Drugs and Pharmaceuticals | 125.77B |
| Strides Pharma Science | 113.84B |